<DOC>
	<DOCNO>NCT02047422</DOCNO>
	<brief_summary>To compare effectiveness safety diuretic add-on strategy chronic heart failure patient</brief_summary>
	<brief_title>A Prospective , Single-center , Randomized , Controlled , Open-label , Pilot Study Compare Effectiveness Safety DIuretics Add-On Strategy Acute Decompensated Heart Failure Patients ( DIOS II )</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Spironolactone</mesh_term>
	<mesh_term>Furosemide</mesh_term>
	<mesh_term>Diuretics</mesh_term>
	<mesh_term>Metolazone</mesh_term>
	<criteria>1. dyspnea rest minimal activity 2. tachypnea ( respiratory rate &gt; 20/min ) rale pulmonary edema chest Xray 1. hospitalization acute heart failure decompensation 2. cardiogenic shock ( Systolic Blood Pressure &lt; 80mmHg ) 3 . Need plan renal replacement therapy ( dialysis , kidney transplant ) 4. serum creatine level &gt; 2.5mg/dl 5. serum potassium ( K+ ) &gt; 5.5mg/dl 6 . Age &gt; 80 year old poor compliance patient 7. allergy , adverse drug reaction , hypersensitivity kind diuretic 8. life expectancy &lt; 6 month ( e.g . metastatic malignancy , liver cirrhosis ) 9. pregnancy woman age childbearing potential</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Heart failure , diuretic , kidney , glomerular filtration rate</keyword>
</DOC>